| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $3.81B | -12.8% |
| Cost of Revenue | $1.06B | -21.1% |
| R&D Expense | $323.7M | -3.2% |
| SG&A Expense | $817.7M | -8.3% |
| Operating Income | -$4.2M | +98.4% |
| Pre-tax Income | -$692.4M | -288.6% |
| Income Tax | -$159.1M | -246.2% |
| Net Income | -$539.9M | -303.0% |
| EPS (Basic) | -$6.49 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.80B | +38.6% |
| Short-term Investments | $0 | -100.0% |
| Accounts Receivable | $519.7M | -3.2% |
| Current Assets | $2.49B | +10.9% |
| Total Assets | $9.55B | -7.9% |
| Current Liabilities | $886.2M | -6.8% |
| Long-term Debt | $1.98B | -2.9% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $354.5M | +87.1% |
| Capital Expenditures | $65.5M | -53.7% |
| Investing Cash Flow | $276.8M | +416.5% |
| Financing Cash Flow | -$129.1M | +42.1% |
| Free Cash Flow | $289.0M | +500.1% |
| -311.4% |
| EPS (Diluted) | -$6.49 | -318.5% |
| Stockholders' Equity |
| $5.58B |
| -8.2% |